Skip to content

Category

gene editing

1,648 papers

#gene editing Open access Sep 2026

🌱 REGENERATION, REPROGRAMMING & REJUVENATION ENGINEERING AT THE LIMIT Stem Cells, Senescence, Tissue Regeneration, Epigenetic Reset, Gene Engineering, and the Emerging Science of Rejuvenation Control

🌱 REGENERATION, REPROGRAMMING & REJUVENATION ENGINEERING AT THE LIMIT Stem Cells, Senescence, Tissue Regeneration, Epigenetic Reset, Gene Engineering, and the Emerging Science of Rejuvenation Control How far can rejuvenation proceed without destroying identity? This flagship research volume explores one of the most di...

33 · 0 citations
#gene editing Review Open access Sep 2026

Mitochondria‐Targeted Nanotherapeutics: A Promising Strategy in Modulating Mitochondrial Function, Transfer, and Transplantation

This review provides a structured synthesis that spans from the biological basis of mitochondrial function and transfer to the broad applications of nanomaterials in mitochondria‐targeted therapies, with a dedicated analysis of their roles in mitochondrial targeting, functional modulation, and gene editing.

Yuan-Yuan Su, Zhi-Yan Gong, Jiao Mu et al. · 0 citations
#gene editing Open access Sep 2026

🌱 REGENERATION, REPROGRAMMING & REJUVENATION ENGINEERING AT THE LIMIT Stem Cells, Senescence, Tissue Regeneration, Epigenetic Reset, Gene Engineering, and the Emerging Science of Rejuvenation Control

🌱 REGENERATION, REPROGRAMMING & REJUVENATION ENGINEERING AT THE LIMIT Stem Cells, Senescence, Tissue Regeneration, Epigenetic Reset, Gene Engineering, and the Emerging Science of Rejuvenation Control How far can rejuvenation proceed without destroying identity? This flagship research volume explores one of the most di...

33 · 0 citations
#gene editing Open access Sep 2026

Clinical Translation of Engineered Cell and Gene Therapies for HIV Cure: A Systematic Review and Target-Product-Profile Gap Analysis of Human Interventional Studies

This systematic review evaluates the clinical translation of engineered cell and gene therapies developed for HIV cure, sustained remission, or durable antiretroviral therapy (ART)-free control. The review focuses on human interventional studies evaluating genetically engineered therapeutic products, including gene-edi...

Nurlan Sadykov · 0 citations
#gene editing Sep 2026

Promoter-Targeted CRISPR Correction of PMP22 Gene Dosage Restores Schwann Cell Homeostasis in Charcot-Marie-Tooth Disease Type 1A.

Collectively, patient-anchored, promoter-targeted genome editing can potentially correct pathogenic PMP22 dosage while preserving basal expression, establishing a translational iPSC-based framework for treating dosage-sensitive demyelinating neuropathies such as CMT1A.

H. Doo, S. H. Nam, Haeun Kim et al. · 0 citations
#gene editing Sep 2026

CRISPR-Cas9 Genome Editing in Mesorhizobium ciceri Through nodC Disruption for Chickpea Symbiosis Studies.

A streamlined genome-editing strategy using a broad-host-range Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9) system adapted for M. ciceri is described, providing an efficient and reproducible framework for precise gene disruption and functional genomics studies in Mesorh...

Nandita Pasari, Nishant Bhandhari, Shruti et al. · 0 citations
#gene editing Review Sep 2026

Safety Challenges and Emerging Solutions in Regenerative Medicine: Tissue Engineering, Cell Therapy, and Gene Therapy.

This commentary highlights key safety concerns across major regenerative medicine categories and emerging solutions to address these risks, along with technological and regulatory approaches in development to improve product safety and consistency.

Seema Kumbhat · 0 citations
#gene editing Open access Sep 2026

In vitro validation of a CRISPR/Cas9 guide RNA targeting COL1A1 gene by cleavage assay.

Functional validation of the gRNAs designed to target exon 2 of the COL1A1 gene is confirmed through in vitro cleavage activity and support its candidate selection for subsequent cellular studies targeting COL1A1, representing an initial step toward future knockout-style cellular models of Osteogenesis Imperfecta.

D. M. Melo, Sabrina Rodrigues Sarquis, Paolla Manzoli Luz et al. · 0 citations
#gene editing Sep 2026

Comparative evaluation of germ cell-specific promoters identifies robust drivers of transgene expression during mouse spermatogenesis

The findings suggest that the Ldhc and Dazl promoters used in this study are robust and are expressed in testicular germ cells, which can be used to study gene regulation during spermatogenesis to understand testicular physiology and male fertility.

S. Koner, Abhishek Das, Shankhamala Chatterjee et al. · 0 citations
#gene editing Review Open access Sep 2026

Emerging roles of microproteins in plant developmental regulation, stress adaptation and crop improvement

This review, primarily focuses on classical plant miPs that modulate protein activity through dominant-negative PPI, while also briefly discussed associated classes of small regulatory peptides, where they intersect functionally with miP-mediated regulation.

Sibani Sahoo, Arpita Jena, Giridara-Kumar Surabhi · 0 citations
#gene editing Open access Sep 2026

Introgressive hybridization fuels local adaptation in oakleaf butterflies

Hybridization may have multiple impacts on speciation and adaptation. Yet the evidence of adaptive introgression events that have historically occurred between nonradiating or established species is still lacking. The oakleaf butterflies in the genus Kallima include multiple sympatric and incipient species with a kno...

Sheng Wang, Pei-Wen Yang, Wei-Fan Lv et al. · 0 citations

From tech blogs

See all →
Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.